Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Aemetis to Review Fourth Quarter and Year End 2023 Financial Results on March 7, 2024
-
Fate Therapeutics to Present at Upcoming March Investor Conferences
-
Karat Packaging to Report 2023 Fourth Quarter and Full Year Financial Results and Host Conference Call on Thursday, March 14, 2024
-
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
-
Changes in the number of own shares held by Aktia Bank Plc
-
Recursion to Participate in Upcoming Investor Conferences
-
Alpha Cognition to Present at the Life Science Investor Forum March 7th
-
Vesting of Performance Share Units and delivery of ISS shares on 1 March 2024
-
Alliance Trust PLC - Total Voting Rights
-
Atlantica Reports 2023 Financial Results
-
Form 8.3 - [WINCANTON PLC] - 29 02 2024 - (CGAML)
-
Form 8.3 - [LXi REIT PLC] - 29 02 2024 - (CGWL)
-
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
-
Man Group PLC : Form 8.3 - Redrow Plc
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC] - 29 02 2024 - (CGWL)
-
Man Group PLC : Form 8.3 - Barratt Developments Plc
-
Man Group PLC : Form 8.3 - UK Commercial Property REIT Limited
-
Man Group PLC : Form 8.3 - Tritax Big Box REIT Plc
-
Oyster Consulting Hires Dan Garrett, Digital and Business Strategy Leader
-
Shenandoah Telecommunications Company to Sell its Towers for $310 Million
-
Li Auto Inc. Hosts 2024 Spring Launch Event
-
Fox River Provides Corporate Update for 2024
-
Sable Announces Preliminary Results from Cerro Negro Greenfields Project in San Juan Argentina
-
Boralex posts record net earnings of $115 million for 2023 and increases its financial flexibility, with nearly $550 million in available cash resources and authorized financing1 to support its growth
-
Highwoods Provides Leasing Update
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
-
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
-
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024
-
U.S. Navy Selects Mercury to Deliver Electronic Warfare Combat Training Subsystems
-
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period
-
WOO X appoints ex-Credit Suisse lead as Chief Product Officer
-
The Macerich Company Announces Grant of Employment Inducement Award in Connection with Appointment of Jackson Hsieh as President and Chief Executive Officer
-
Bitfarms Earns 300 BTC in February 2024; Provides Update on Fleet Upgrade
-
ATHA Energy Announces Approval to List on TSXV and Receipt of Final Order for Arrangement With Latitude Uranium
-
Christina Lake Closes First Tranche of Non-Brokered Private Placement of Secured Convertible Notes
-
Solaris Announces Cooperation Agreement with Interprovincial Federation of Shuar Centers and the Alliance for Entrepreneurship and Innovation of Ecuador
-
Plug Highlights Year of Strategic Growth and Advancements in Accelerating the Green Hydrogen Economy
-
Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma
-
iTeos to Participate in Upcoming Investor Conferences
-
Immunocore to present at upcoming investor conferences
-
Transactions by persons discharging managerial responsibilities and/or persons closely associated
-
Vital Voices Kicks Off Women’s History Month with an Interactive Art Exhibit at the United Nations and our 17th Annual Global Mentoring Walks
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wincanton plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AGEAS - Ordinary Shares
-
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
-
Closing of the sale of Paide and Valka cogeneration plants
-
Correction: HSBC Bank Plc - Form 8.5 (EPT/RI) - Wincanton plc
-
Festi hf.: Multiplication election at the Annual General Meeting on March 6, 2024
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TRITAX BIG BOX REIT PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Redrow plc - Ordinary Shares
